Free Cash Flow Chart

View Free Cash Flow for GH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Free Cash Flow Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -228.54M
March 31, 2026 -225.08M
December 31, 2025 -233.07M
September 30, 2025 -274.52M
June 30, 2025 -284.02M
March 31, 2025 -317.01M
December 31, 2024 -274.94M
September 30, 2024 -274.36M
June 30, 2024 -299.26M
March 31, 2024 -300.71M
December 31, 2023 -345.46M
September 30, 2023 -363.41M
June 30, 2023 -383.13M
March 31, 2023 -417.57M
December 31, 2022 -386.92M
Date Value
September 30, 2022 -387.79M
June 30, 2022 -363.20M
March 31, 2022 -309.49M
December 31, 2021 -284.05M
September 30, 2021 -248.94M
June 30, 2021 -191.49M
March 31, 2021 -143.10M
December 31, 2020 -157.99M
September 30, 2020 -128.91M
June 30, 2020 -118.17M
March 31, 2020 -102.18M
December 31, 2019 -68.42M
September 30, 2019 -60.46M
June 30, 2019 -81.32M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Natera, Inc. 51.20M
NeoGenomics, Inc. -7.355M
Quest Diagnostics, Inc. 1.349B
Labcorp Holdings, Inc. 1.155B
OPKO Health, Inc. -134.02M